PT-2385
≥99%
- Product Code: 102168
CAS:
1672665-49-4
| Molecular Weight: | 383.34 g./mol | Molecular Formula: | C₁₇H₁₂F₃NO₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
PT-2385 is primarily used in research settings to study and target hypoxia-inducible factor-2α (HIF-2α), a protein that plays a critical role in cellular responses to low oxygen levels. It is being investigated for its potential therapeutic applications in cancers where HIF-2α is overexpressed, such as renal cell carcinoma (RCC). By inhibiting HIF-2α, PT-2385 aims to disrupt tumor growth and survival mechanisms driven by hypoxia. Additionally, it is explored for its effects on conditions where oxygen regulation is impaired, offering insights into novel treatment strategies. Its development underscores its importance in advancing targeted cancer therapies.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 100 |
| Infrared Spectrum | Conforms To Structure |
| 1 H NMR Spectrum | Consistent With Structure |
| LCMS | Consistent With Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿4,460.00 |
+
-
|
| 0.005 | 10-20 days | ฿5,980.00 |
+
-
|
| 0.025 | 10-20 days | ฿20,580.00 |
+
-
|
PT-2385
PT-2385 is primarily used in research settings to study and target hypoxia-inducible factor-2α (HIF-2α), a protein that plays a critical role in cellular responses to low oxygen levels. It is being investigated for its potential therapeutic applications in cancers where HIF-2α is overexpressed, such as renal cell carcinoma (RCC). By inhibiting HIF-2α, PT-2385 aims to disrupt tumor growth and survival mechanisms driven by hypoxia. Additionally, it is explored for its effects on conditions where oxygen regulation is impaired, offering insights into novel treatment strategies. Its development underscores its importance in advancing targeted cancer therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :